Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance

(2012) N. B. Jørgensen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Effects of Diet Soda on Gut Hormones in Youths With Diabetes

(2012) R. J. Brown et al.   DIABETES CARE

GLP-1 Response to a Mixed Meal: What Happens 10 Years after Roux-en-Y Gastric Bypass (RYGB)?

(2012) Moahad S. Dar et al.   OBESITY SURGERY

Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects

(2012) Fabiola Romero et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

(2011) J. J. Holst et al.   DIABETES CARE

Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study

(2011) C. Beysen et al.   DIABETOLOGIA

Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes

(2011) Jonatan I. Bagger et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A1c in individuals with well-controlled type 2 diabetes mellitus

(2011) Ashley E. Cohen et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes

(2010) Junji Kozawa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action

(2010) K. J. Hare et al.   DIABETES

Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes

(2010) Seung Jin Han et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

(2010) M. A. Nauck et al.   DIABETOLOGIA

Intact Glucagon-like Peptide-1 Levels are not Decreased in Japanese Patients with Type 2 Diabetes

(2010) Soushou LEE et al.   ENDOCRINE JOURNAL

Effects of meal size and composition on incretin, α-cell, and β-cell responses

(2009) Josina M. Rijkelijkhuizen et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery

(2009) Mousumi BOSE et al.   Journal of Diabetes

Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects

(2008) Jerry R Greenfield et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

First-Phase Insulin Secretion Restoration and Differential Response to Glucose Load Depending on the Route of Administration in Type 2 Diabetic Subjects After Bariatric Surgery

(2008) S. Salinari et al.   DIABETES CARE

Insulin Regulates Glucagon-Like Peptide-1 Secretion from the Enteroendocrine L Cell

(2008) Gareth E. Lim et al.   ENDOCRINOLOGY

Measuring the Effect of a Study Meal on Portal Concentrations of Glucagon-Like Peptide 1 (GLP-1) in Non Diabetic and Diabetic Patients with Liver Cirrhosis: Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) as a New Method for Metabolic Measurements

(2008) D. Raddatz et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Is secretion of glucagon-like peptide-1 reduced in type 2 diabetes mellitus?

(2008) Juris J Meier et al.   Nature clinical practice. Endocrinology & metabolism